ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2024 and some content may be unavailable. To unlock all content for 2024, please visit the archives.

Abstract: TH-PO045

Dietary Supplementation with Bacillus Superoxide Dismutase Protects against Contrast-Induced AKI in Mice

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

  • Choi, Young Eun, Korea University Anam Hospital, Seoul, Korea (the Republic of)
  • Jang, Yookyung, Korea University Anam Hospital, Seoul, Korea (the Republic of)
  • Yoon Sook, Ko, Korea University Anam Hospital, Seoul, Korea (the Republic of)
  • Hee Young, Lee, Korea University Anam Hospital, Seoul, Korea (the Republic of)
  • Koo, Tai yeon, Korea University Anam Hospital, Seoul, Korea (the Republic of)
  • Oh, Sewon, Korea University Anam Hospital, Seoul, Korea (the Republic of)
  • Kim, Myung-Gyu, Korea University Anam Hospital, Seoul, Korea (the Republic of)
  • Jo, Sang-Kyung, Korea University Anam Hospital, Seoul, Korea (the Republic of)
  • Yang, Jihyun, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Korea (the Republic of)
Background

Superoxide dismutase (SOD) is a metalloenzyme that play an important role in antioxidant defense against oxidative stress. Oxidative stress was known as one of the main pathophysiology in contrast-induce acute kidney injury (CI-AKI). Based on recent data showing the important role of gut dysbiosis, using probiotics could have a potential to modify systemic oxidative stress. We investigated the renoprotective potential of orally administered enteric-coated SOD protein purified from Bacillus amyloliquefaciens (SOD-BA) in contrast-induced acute kidney injury (CI-AKI) in mice.

Methods

CI-AKI model was induced with unilateral nephrectomy using 5 week-old C57BL/6 male mice. Giving oral gavage SOD-BA once a day, 48 hours before intravenous contrast injection (10mg/kg) 4 weeks after unilateral nephrectomy. Serum blood urea nitrogen (BUN), creatinine, and kidney tissue NGAL were determined.

Results

SOD-BA did not have kidney toxicity in the vehicle group. The unilateral CI-AKI model showed minimal kidney function deterioration based on creatinine level. However, the serum BUN and NGAL were strikingly increased. SOD-BA oral administration group showed decreased BUN and kidney NGAL level.

Conclusion

Prophylactic treatment of oral SOD-BA could serve as a potent antioxidant in the prevention and treatment of CI-AKI.

Funding

  • Commercial Support – Department of, Biomlogic/Genofocus

Digital Object Identifier (DOI)